Navigation auf


Schweizer Institut für Sucht- und Gesundheitsforschung

Michael Schaub

Michael Schaub, Prof. Dr. phil.

  • Scientific Director
+41 44 448 11 65

Main research interests

  • Therapy and prevention intervention research for the reduction/cessation of substance use disorders
  • Addiction prevention and therapy on the Internet
  • Evaluation and quality research in the area of substance use disorders
  • Epidemiology of illicit drug consumption

Curriculum vitae

Dr. Michael P. Schaub is Associate Professor at the University of Zurich and the Scientific Director of the Swiss Research Institute of Public Health and Addiction ISGF, a WHO Collaborating Centre, associated with the University of Zurich. He is a trained psychotherapist with a strong clinical and scientific background as well as a public health expert in the area of substance use disorders and behavioral addictions. He completed his Ph.D. in 2005 on the topic of cannabis use, its associated personality dimensions in the general population, and co-occurring mental-health problems in vulnerable persons. In 2012 he received his postdoctoral lecture qualification (Habilitation) for psychology, with the specialization for “treatment and diagnostic of substance use disorders” at the University of Zurich and was appointed Associate Professor in 2019. In 2014, Dr. Schaub received the Best Scientific Paper Award from the European Monitoring Center for Drugs and Drug Addiction (EMCDDA). One of his current main focus is on internet interventions for the reduction of substance use and substance use disorders as well as for the treatment of behavioral addictions. As such, he led amongst others the first low- and middle-income study among internet interventions in the field of substance use disorders evaluating the effectiveness of the WHO web-based self-help intervention Alcohol e-help in Belarus, Brazil, India and Mexico.

Dr. Schaub has published more than 120 peer-reviewed papers in scientific journals. He is scientific expert in addiction research for the World Health Organization WHO and at the United Nations Office on Drugs and Crime UNODC. Moreover, he is appointed member to the Technical Advisory Group on the Mental Health Impacts of COVID-19 in the WHO European Region.


ZORA Publication List

Download Options